Fractyl Health, Inc.
Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 11 Sep 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 17 Mar 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Fractyl Health, Inc. — Overview & Financial Snapshot
Fractyl Health, Inc. (NasdaqGM: GUTS) is a Healthcare company, ranked #6,600 of 6,774 companies globally and #3,840 of 4,000 in United States on PositoAI, with a Positivity Score of -28,954. Its market capitalisation is ₹141.49 Cr ($14.99M), P/E ratio is -0.1 and P/B ratio is -9.00. It currently has 2 active red flags (PosiRed) and no yellow flags (PosiYellow) on record.
For financial statements, ratio trends and score history, Go Deep →